| TRIYO Otsuka Pharmaceutical Co., Ltd.
2322211 21 Feb 2024 | on 17 Apr 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | | | TRIYO Otsuka Pharmaceutical Co., Ltd.
2322212 21 Feb 2024 | on 17 Apr 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | | | TRIYO Otsuka Pharmaceutical Co., Ltd.
2322213 21 Feb 2024 | on 17 Apr 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | | | TRIYO Otsuka Pharmaceutical Co., Ltd.
2322214 21 Feb 2024 | on 17 Apr 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | | | TRIYO Otsuka Pharmaceutical Co., Ltd.
2322215 21 Feb 2024 | on 17 Apr 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | | | TRIYO OTSUKA PHARMACEUTICAL CO. LTD.
2314198 12 Jan 2024 | on 06 Mar 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; neurological and psychological pharmaceutical preparations for the treatment of eating disorders and addictions; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions. | | 
